Wykłady otwarte w ramach studiów S-DISCO

Katedra i Zakład Technologii Chemicznej Środków Leczniczych Gdańskiego Uniwersytetu Medycznego jest organizatorem zajęć w ramach przedmiotu Computational methods in drug design na nowo otwartym kierunku Sustainable Drug Discovery (S-DISCO) na Wydziale Farmaceutycznym. Zajęcia będą prowadzone przez naukowców z Francji w dniach 30 maja 2023 r. w godz. 9:00-14:00, 31 maja 2023 r. w godz. 9:00-13:00 i 1 czerwca 2023 r. w godz. 9:00-13:00. Wykłady prowadzone będą stacjonarnie w Budynku Głównym Wydziału Farmaceutycznego GUMed (dla studentów S-DISCO) oraz w formie online na platformie ZOOM. Inicjatywa skierowana jest zarówno do studentów, jak i pracowników GUMed. Do udziału w spotkaniu konieczna jest uprzednia rejestracja internetowa.

Sylwetki prelegentów

Matthieu Montes is a Professor of Structural Bioinformatics in Conservatoire National des Arts et Métiers, Paris (FR). He is an ERC fellow (2015-2021, 2022-2023) with expertise in high throughput ligand screening, chemoinformatics, biomolecular recognition and molecular visualization and interactive simulation. He collaborates closely with experimental groups and actively develops methods and tools for ligand design (including NR-DBIND database), molecular visualization (VTX) and protein docking (UDock).

Amaury Farce – his research activities have begun with a PhD thesis in applied molecular modeling in medicinal chemistry projects revolving around depression, obesity and cancer with targets belonging mainly to the GPCRs and nuclear receptors superfamillies. These two classes are still his main interests, with a twist toward the effect of the unwanted modulation of nuclear receptors by endocrine perturbators, both for prediction and explanation of biological effects, in nation wide consortia. Local collaborative projects at Lille with biologists and chemists and the input from clinicians have lead to open new possibilities in the field of cancer (targeting YAP-TEAD interaction), or parasites, with new targets to treat malaria (PPM9) and toxoplasmosis (at the kystic bradyzoite stage) or the investigation of the molecular mechanism of action of an immunomodulator protein from a schistozome that has shown a potential in the treatment of chronic inflammation. All these projects were conducted with in silico tools from the bioinformatic and chemoinformatic fields, ranging from QSAR to homology modeling.

Nicolas Renault obtained his PhD degree in 2010 studying structure-function relationships and further virtual screening of some GPCR pharmacological targets. Research engineer in computational chemistry for 7 years in a research unit dedicated to inflammation, he develops some chemoinformatics solutions to elucidate key protein structural mechanisms and identify first hit compounds targeting proteins involved in inflammation (immune checkpoints, cellular pores, mucins).

Dane dostępowe do spotkania online:
Bezpośredni link https://us06web.zoom.us/j/82787799821?pwd=V2lOSzZFV1JpY2R4WnF0WWhZRDZzdz09
ID spotkania 827 8779 9821
Kod dostępu 0m&ZQx@g

Inicjatywa realizowana jest w ramach projektu POWER.03.05.00-22-Z082/18.